A multicenter, retrospective observational study investigating baseline characteristics and clinical outcomes in patients with hormone-sensitive prostate cancer treated with primary androgen deprivation therapy.

Taguchi, Satoru; Onozawa, Mizuki; Hinotsu, Shiro; Kawai, Taketo; Mitomi, Takeshi; Uno, Satoshi; Kume, Haruki

Taguchi, Satoru; Onozawa, Mizuki; Hinotsu, Shiro; Kawai, Taketo; Mitomi, Takeshi; Uno, Satoshi; Kume, Haruki.

Afiliação

Taguchi S; Department of Urology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Onozawa M; Japan Study Group of Prostate Cancer (J-CaP) Research Society, Japan.
Hinotsu S; Japan Study Group of Prostate Cancer (J-CaP) Research Society, Japan.
Kawai T; Department of Urology, International University of Health and Welfare Ichikawa Hospital, Ichikawa, Japan.
Mitomi T; Japan Study Group of Prostate Cancer (J-CaP) Research Society, Japan.
Uno S; Department of Biostatistics, Sapporo Medical University, Sapporo, Japan.
Kume H; Japan Study Group of Prostate Cancer (J-CaP) Research Society, Japan.

Jpn J Clin Oncol ; 53(10): 957-965, 2023 Oct 04.

Article em En | MEDLINE | ID: mdl-37408443

Palavras-chave

castration; degarelix; goserelin; leuprorelin; prostate cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google